Correlation Between Sanofi ADR and Gilead Sciences

Can any of the company-specific risk be diversified away by investing in both Sanofi ADR and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sanofi ADR and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sanofi ADR and Gilead Sciences, you can compare the effects of market volatilities on Sanofi ADR and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sanofi ADR with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sanofi ADR and Gilead Sciences.

Diversification Opportunities for Sanofi ADR and Gilead Sciences

0.07

Correlation Coefficient

Sanofi ADR  Gilead Sciences

Significant diversification

The 3 months correlation between Sanofi and Gilead is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Sanofi ADR and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and Sanofi ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sanofi ADR are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of Sanofi ADR i.e., Sanofi ADR and Gilead Sciences go up and down completely randomly.

Pair Corralation between Sanofi ADR and Gilead Sciences

Considering the 90-day investment horizon Sanofi ADR is expected to generate 1.83 times more return on investment than Gilead Sciences. However, Sanofi ADR is 1.83 times more volatile than Gilead Sciences. It trades about 0.07 of its potential returns per unit of risk. Gilead Sciences is currently generating about -0.32 per unit of risk. If you would invest  4,780  in Sanofi ADR on February 4, 2024 and sell it today you would earn a total of  121.00  from holding Sanofi ADR or generate 2.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

Sanofi ADR  vs.  Gilead Sciences

Sanofi ADR

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sanofi ADR are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Sanofi ADR is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Gilead Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gilead Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in June 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Sanofi ADR and Gilead Sciences

The main advantage of trading using opposite Sanofi ADR and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sanofi ADR position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.

The idea behind Sanofi ADR and Gilead Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.